Examination for the effect of combination therapy with raloxifene and eldecalcitol in primary osteoporotic patients - Switch from alfacalcidol to eldecalcitol.
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2014
At a glance
- Drugs Eldecalcitol (Primary) ; Raloxifene (Primary) ; Alfacalcidol
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 10 May 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 22 Apr 2012 New trial record